Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group To Launch A Longevity & Wellness Initiative Globally; Orgenesis And HSHG Will Establish A JV, With Orgenesis Owning 49% And HSHG Owning 51% Of The Entity; HSHG Has Agreed To Invest Up To $10M Over 3-Years Into Orgenesis And The Joint Venture

Author: Benzinga Newsdesk | August 14, 2024 07:39am

Orgenesis Inc. (NASDAQ:ORGS) ("Orgenesis" or the "Company"), a global biotech company working to unlock the full potential of cell and gene therapies (CGT) in order to improve access and outcomes in healthcare, today announced a strategic partnership agreement with Harley Street Healthcare Group (HSHG) – an innovative and forward-looking healthcare provider focused on delivering world-class, proactive, personalized and preventative health & wellness services, based in London with a global presence. This partnership aims to accelerate the clinical development and commercialization of advanced wellness and longevity therapies and products to a global customer base, aimed at significantly reducing the impact of lifestyle-related illnesses on people's health.

 

Under the terms of the agreement, Orgenesis and HSHG will establish a joint venture (JV), with Orgenesis owning 49% and HSHG owning 51% of the entity. The JV will focus on launching innovative health and wellness services, including personalized preventative care and regenerative therapies. The goal is to establish a comprehensive "Health-Wellness-as-a-Service" (HWAAS) model, leveraging HSHG's established healthcare network and Orgenesis' cutting-edge biotech innovations.

Posted In: ORGS